Clinical trials
Suspended Phase 1/2 trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gemma Biotherapeutics | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| REGENXBIO Inc. | 1 |
| University of Sao Paulo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homocystinuria | 1 |
| Leukodystrophy, Globoid Cell | 1 |
| Lysosomal Storage Diseases | 1 |
| Mucopolysaccharidosis I | 1 |
| Rare Diseases | 1 |
| Stroke | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.